Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04902768 · ClinicalTrials.gov registry record
Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II
A clinical trial of Congenital Heart Disease, sponsored by KU Leuven.
- Completed
- Registry status
- 8,415
- Enrollment target
- 20
- Study locations
NCT04902768 is a study of Congenital Heart Disease that has completed, run by KU Leuven. The registered enrollment target is 8,415 participants, above the 340-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (2375% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT04902768, a study of Congenital Heart Disease, has completed, sponsored by KU Leuven.
- COMPLETED
- Registry status
- 8,415 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is an international, cross-sectional and descriptive study that aims to investigate differences in patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) and that aims to explore the profile and healthcare needs of adults with congenital heart diseases.
Conditions Studied
Interventions
- OTHER This is an observational study, there is no intervention
Study Locations (20)
Other
- Hospital San Juan De Dios De La Plata - Buenos Aires
- Hospital de Niños - Córdoba
- Melbourne Children's Cardiology - Melbourne
- Vienna General Hospital - Vienna
- Ghent University Hospital - Ghent
- University Hospitals Leuven - Leuven
- Princess Marina Hospital - Gaborone
- Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto - Ribeirão Preto
- National Heart Hospital - Sofia
- Clinique Medical Le Jourdain - Yaoundé
California
- University of California - San Francisco
- Lucile Packard Children's Hospital and Stanford Health Care - Stanford
Florida
- University of Florida Health - Gainesville
Maryland
- Taussig Heart Center of Johns Hopkins Hospital - Baltimore
Massachusetts
- Boston Children's / Brigham and Women's - Boston
New York
- Mount Sinai Heart - New York
Ohio
- Nationwide Children's Hospital - Columbus
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,415 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04902768
The ClinicalTrials.gov registry entry for NCT04902768 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8,415 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 340-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (2375% higher). The listed sponsor is KU Leuven, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which This is an observational study, there is no intervention is the first listed.
NCT04902768 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04902768 about?
NCT04902768 is a clinical study titled "Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II". This is an international, cross-sectional and descriptive study that aims to investigate differences in patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) and that aims to explore the profile and healthcare needs of adults with congenital heart diseases.
What is the current status of trial NCT04902768?
This trial is currently completed. The enrollment target is 8,415 participants. The study started on 2019-08-01. Estimated completion is 2022-12-31.
What conditions does trial NCT04902768 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT04902768?
The interventions under investigation include: This is an observational study, there is no intervention (OTHER).
Who is sponsoring clinical trial NCT04902768?
This trial is sponsored by KU Leuven, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04902768 being conducted?
This trial has 20 study locations across California, Florida, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.